AV
Alexandria Venture Investments
Venture CapitalActiveAlexandria Venture Investments is a venture capital firm that develops the work in real estate technology, and healthcare sectors.
94
Investments
10
Exits
$2.5B
AUM
10.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Alexandria Venture Investments.
Investment Thesis & Strategy
Alexandria Venture Investments invests in various stages of real estate technology and healthcare companies, seeking to support innovative ventures within these specific sectors.
Notable Exits
CompanyTypeYearValue / Acquirer
Obsidian TherapeuticsAcquisition2024—
Turning Point TherapeuticsAcquisition2022$4.1B
Ventyx BiosciencesIPO2022—
SeerIPO2021—
Zentalis PharmaceuticalsIPO2020—
Revolution MedicinesIPO2020—
Gossamer BioIPO2018—
Acerta PharmaAcquisition2015—
Kura OncologyIPO2015—
Puma BiotechnologyIPO2014—
Frequently Asked Questions
Alexandria Venture Investments focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Arcturus Capital
Pasadena, United States · 15 deals
Mount Wilson Ventures
Pasadena, United States · 14 deals
Momentum Venture Management
Pasadena, United States · 13 deals
Wavemaker 360
Pasadena, United States · 12 deals
Himalaya Capital Ventures
Pasadena, United States · 9 deals
IdeaLab Capital Partners
Pasadena, United States · 4 deals